Bifidobacterium longum RAPO Ameliorates Anti-tumor Efficacy and Immune-Related Adverse Events of Anti-PD-1 Therapy in a Mouse Model of Triple-Negative Breast Cancer

OBJECTIVES: Immune checkpoint inhibitors (ICIs) have been considered as a novel treatment of triple negative breast cancer (TNBC) representing higher risk of early metastasis and relapse. ICIs induce immune-related adverse events (irAEs) including myocarditis, pneumonitis, hepatitis, nephritis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeyoon, Oh, Rira, Heo, Ji-Won, Ji, Geun Eog, Park, Myeong Soo, Kim, Sung-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Nutritional Immunology and Inflammation/Immunometabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194227/
http://dx.doi.org/10.1093/cdn/nzac068.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194227/
http://dx.doi.org/10.1093/cdn/nzac068.015

Ejemplares similares